-
公开(公告)号:US20010023244A1
公开(公告)日:2001-09-20
申请号:US09753655
申请日:2001-01-04
申请人: Astra Aktiebolag
IPC分类号: A61K038/05 , C07D25/04
CPC分类号: C07K5/06026 , A61K38/00 , C07K5/0222
摘要: There is provided EtO2CnullCH2null(R)CglnullAzenullPabnullOH, or a pharmaceutically-acceptable salt thereof, in a form which is substantially crystalline. It has been found that crystalline forms of EtO2CnullCH2null(R)CglnullAzenullPabnullOH have a high chemical and solid state stability when compared to amorphous forms of the compound.
摘要翻译: 提供了基本上是结晶形式的EtO 2 C-CH 2 - (R)Cgl-Aze-Pab-OH或其药学上可接受的盐。 已经发现,与化合物的无定形形式相比,EtO 2 C-CH 2 - (R)Cgl-Aze-Pab-OH的结晶形式具有高的化学和固态稳定性。